TY -的T1的附带损害COVID-19 JF -神经学乔-神经病学SP - 219 LP - 220 - 首页10.1212 / WNL。0000000000013196 VL - 98 IS - 6 AU - Jonika Tannous AU - Farhaan S. Vahidy Y1 - 2022/02/08 UR - //www.ez-admanager.com/content/98/6/219.abstract N2 - The SARS-CoV-2 virus has infected >250 million people worldwide, including 46 million in the United States. This represents approximately 3.2% of the global and 14% of the US population. Because of major disruptions to medical systems worldwide, the effect of the COVID-19 pandemic on health goes beyond the number of directly infected people. For example, from the earliest days of the pandemic, significant disruptions in acute cerebrovascular evaluations were observed,1 followed by consistent reports of uncharacteristic declines in acute stroke admissions to hospitals in the United States and other countries.2 As the COVID-19 pandemic waves hit various regions of the globe, the health care systems pivoted to direct all available resources towards acute in-hospital critical care of infected patients. Although necessary, this shift came at the expense of preventive and chronic care management. The emerging pandemic therefore constituted a perfect storm for older adults and for those with the most need for chronic risk and disease management. On one hand, they were highly susceptible to infection and poor COVID-19 outcomes; and on the other, disruptions in regular care made them more vulnerable to incident or worsening chronic disease outcomes. Until recently, the effect of the pandemic on population health strategies for primary and secondary stroke prevention that are critical to reducing cerebrovascular disease burden has not been well studied. ER -